Novavax to Present at Two Upcoming Investor Conferences
September 26 2018 - 4:05PM
Novavax to Present at Two Upcoming Investor Conferences
Novavax, Inc. (NASDAQ: NVAX) today announced that it will present
at the Ladenburg Thalmann 2018 Healthcare Conference and the Cantor
Global Healthcare Conference 2018, both in the first week of
October.
Conference details are as follows:
Ladenburg Thalmann 2018 Healthcare
Conference
|
Date and
Time:Location:Live
webcast: |
|
Tuesday, October 2, 12:00 p.m. – 12:25 p.m.Track 5, Montmartre,
Sofitel New Yorkwww.novavax.com, “Investors”/“Events” |
| |
|
|
Cantor Global Healthcare Conference
2018
|
Date and
Time:Location:Live
webcast: |
|
Wednesday, October 3, 10:55 a.m. – 11:25 p.m.Track 2, Empire
Ballroom 1, InterContinental New York Barclay Hotelwww.novavax.com,
“Investors”/“Events” |
| |
|
|
A replay of the presentations will also be
accessible under the “Investors/Events” section
www.novavax.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a late-stage
biotechnology company that drives improved health globally through
the discovery and development of innovative vaccines to prevent
serious respiratory diseases. ResVax™, its RSV vaccine for infants
via maternal immunization, is the only vaccine in a Phase 3
clinical program and is poised to help prevent the second leading
cause of death in children under one year of age worldwide. Novavax
is also advancing NanoFlu™, its quadrivalent influenza nanoparticle
vaccine, to address key factors that can lead to the poor
effectiveness of currently approved flu vaccines. Novavax is a
leading innovator of recombinant vaccines; its proprietary
recombinant technology platform combines the power and speed of
genetic engineering to efficiently produce a new class of highly
immunogenic nanoparticles addressing urgent global health
needs.
For more information, visit www.novavax.com and
connect with us on Twitter and LinkedIn.
Contact:
InvestorsNovavax, Inc.Erika TrahanSenior Manager, Investor &
Public Relationsir@novavax.com240-268-2000
Westwicke PartnersJohn
Woolfordjohn.woolford@westwicke.com443-213-0506
MediaSam BrownMike Beyermikebeyer@sambrown.com312-961-2502
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024
